{"id":"NCT01165281","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain","officialTitle":"A Randomized, Double-Blind, Active Controlled, Optimal Dose Titration, Multicenter Study to Evaluate the Safety and Efficacy of Oral JNS024 Extended Release (ER) in Japanese and Korean Subjects With Moderate to Severe Chronic Malignant Tumor Related Cancer Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-08","primaryCompletion":"2012-08","completion":"2012-08","firstPosted":"2010-07-19","resultsPosted":"2014-01-15","lastUpdate":"2017-07-21"},"enrollment":343,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain"],"interventions":[{"type":"DRUG","name":"Oxycodone CR","otherNames":[]},{"type":"DRUG","name":"R331333 (referred to as JNS024 ER or CG5503)","otherNames":[]}],"arms":[{"label":"001","type":"EXPERIMENTAL"},{"label":"002","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of R331333 (referred to as JNS024 Extended-Release (ER) or CG5503) compared with an active comparator (oxycodone Controlled Release (CR)) in Japanese and Korean patients with chronic, malignant, tumor-related cancer pain.","primaryOutcome":{"measure":"Change From Baseline to the Last 3 Days of Study Drug Administration (Last Observation Carried Forward) in the Score for Average Pain Intensity on an 11-point Numerical Rating Scale","timeFrame":"Baseline, Last 3 Days of Study Drug Administration (4 weeks)","effectByArm":[{"arm":"Tapentadol (JNS024) Extended-release (ER) Oral Tablets","deltaMin":-2.69,"sd":2.223},{"arm":"Oxycodone Controlled-release (CR) Oral Tablets","deltaMin":-2.57,"sd":2.027}],"pValues":[{"comp":"OG000 vs OG001","p":"0.786"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":52,"countries":["Japan","South Korea"]},"refs":{"pmids":["23937387"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":78,"n":168},"commonTop":["Constipation","Nausea","Vomiting","Somnolence","Decreased appetite"]}}